This information is for PAGB members only and is not to be reproduced, repeated or circulated without PAGB’s permission.
Webinar on the Responsible Manufacturing Effluent Management Technical Guidance Document
AESGP, EFPIA and Medicines for Europe are hosting a webinar on the Responsible Manufacturing Effluent Management Technical Guidance Document (TGD).The TGD was released by the Inter Association Initiative Pharmaceuticals in the Environment Task Force in October 2020 and subsequently endorsed by the three participating association boards. The paper is intended as technical guidance for the pharmaceutical industry to help identify and mitigate the potential impacts of active pharmaceutical ingredients (API) in wastewater from manufacturing operations. The approaches it describes are intended as general guidelines for carrying out risk assessments in different exposure scenarios for APIs in manufacturing effluent and for implementing such programs.The webinar will provide insight into the background and key elements of the TGD, including case studies, to raise awareness about the risk-based and incremental approach in the guideline and ultimately help companies to implement these guidelines. The presentation will be followed by a Q&A session.Speakers: Andreas Häner (Roche), Sam Maynard (AstraZeneca) & Birgit Mertens (Johnson & Johnson).When: 18 February at 2.00 – 3.30pm (GMT)
Responsible Manufacturing Effluent Management Technical Guidance DocumentJoin the webinar: https://zoom.us/j/95775747895?pwd=NjFoNXVjdExpSnIrZy8ydlFuQWN2QT09Meeting ID: 957 7574 7895Passcode: 890393
View more regulatory intelligence relating to medicines, medical devices and food supplements issues View our EU Exit blog here to stay on top of the latest from PAGB, Government, regulators and other stakeholders View our COVID-19 blog here for important announcements and updates related to the pandemic to support your business.
Return to environment archive
